
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Galactosemia classification
Introduction
Overview
Overview
Galactosemia consists of four types of disorders resulting from abnormal activity of the enzymes involved in galactose metabolism. Type I/ Classical is the most serious form of the disease.
Types
Types
Galactosemia refers to a group of autosomal recessive disorders of galactose metabolism. They are classified into the following types based on the enzymatic activity [1]
Type I/Classical
- Defects in both copies of the gene that codes for the enzyme galactose-1-phosphate uridyl transferase or GALT.[2].
- Most common and severe form.
- Duarte galactosemia
- Variant of classic galactosemia.
- Galactose metabolised to some extent as GALT not completely absent
- Less severe symptoms than other forms
- Duarte galactosemia
Type II
- Defect in both copies of the gene that codes for the enzyme galactokinase or GALK.[3]
- Less common and harmful than classic galactosemia.
- Does not generally lead to hepatomegaly or brain damage.
Type III
Type IV
- This type has only been discovered recently.
- Abnormal changes in the galactose mutatrose enzyme, encoded by the GALM gene, have been proven to cause the disorder. [5]
References
References
- ↑ Banford S, McCorvie TJ, Pey AL, Timson DJ (2021). “Galactosemia: Towards Pharmacological Chaperones”. J Pers Med. 11 (2). doi:10.3390/jpm11020106. PMC 7914515 Check
|pmc=value (help). PMID 33562227 Check|pmid=value (help). - ↑ Coelho AI, Rubio-Gozalbo ME, Vicente JB, Rivera I (2017). “Sweet and sour: an update on classic galactosemia”. J Inherit Metab Dis. 40 (3): 325–342. doi:10.1007/s10545-017-0029-3. PMC 5391384. PMID 28281081.
- ↑ Holden HM, Thoden JB, Timson DJ, Reece RJ (2004). “Galactokinase: structure, function and role in type II galactosemia”. Cell Mol Life Sci. 61 (19–20): 2471–84. doi:10.1007/s00018-004-4160-6. PMID 15526155.
- ↑ Timson DJ (2006). “The structural and molecular biology of type III galactosemia”. IUBMB Life. 58 (2): 83–9. doi:10.1080/15216540600644846. PMID 16611573.
- ↑ Banford S, Timson DJ (2021). “The structural and molecular biology of type IV galactosemia”. Biochimie. 183: 13–17. doi:10.1016/j.biochi.2020.11.001. PMID 33181226 Check
|pmid=value (help).
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dayana Davidis, M.D. [2]
